AR008155A1 - Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. - Google Patents
Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.Info
- Publication number
- AR008155A1 AR008155A1 ARP970103968A ARP970103968A AR008155A1 AR 008155 A1 AR008155 A1 AR 008155A1 AR P970103968 A ARP970103968 A AR P970103968A AR P970103968 A ARP970103968 A AR P970103968A AR 008155 A1 AR008155 A1 AR 008155A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- formula
- women
- menopausic
- treat
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de un compuesto de fórmula I para la manufactura de un medicamento útil para tratar enfermedades cardiovasculares en mujeres posmenopáusicas. Elidoxifeno es el compuesto preferido.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2543996P | 1996-09-06 | 1996-09-06 | |
| US5066697P | 1997-06-24 | 1997-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR008155A1 true AR008155A1 (es) | 1999-12-09 |
Family
ID=26699738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103968A AR008155A1 (es) | 1996-09-06 | 1997-08-29 | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0927029A4 (es) |
| JP (2) | JP2002515046A (es) |
| KR (2) | KR20000068473A (es) |
| CN (2) | CN1236313A (es) |
| AR (1) | AR008155A1 (es) |
| AU (2) | AU4409797A (es) |
| BR (2) | BR9711681A (es) |
| CA (2) | CA2264775A1 (es) |
| CO (2) | CO5070658A1 (es) |
| CZ (1) | CZ76699A3 (es) |
| IL (1) | IL128645A0 (es) |
| NO (2) | NO991096L (es) |
| PL (2) | PL332278A1 (es) |
| TR (2) | TR199900504T2 (es) |
| TW (1) | TW411273B (es) |
| WO (2) | WO1998009519A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998034608A1 (en) * | 1997-02-11 | 1998-08-13 | Novo Nordisk A/S | Methods for treatment or prophylaxis of menopausal symptoms |
| GB9827121D0 (en) * | 1998-12-09 | 1999-02-03 | Orion Corp | Agent for lowering endothelin levels |
| DE19905961A1 (de) * | 1999-02-12 | 2000-08-17 | Stefan Neubauer | Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz |
| US6528681B2 (en) * | 2000-04-05 | 2003-03-04 | Bristol-Meyers Squibb Pharma Company | Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| IL145876A0 (en) | 2000-10-17 | 2002-07-25 | Pfizer Prod Inc | Methods and kits for improving vascular health |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0260066B1 (en) * | 1986-09-11 | 1990-05-09 | National Research Development Corporation | Tamoxifen derivatives |
| JPH09500863A (ja) * | 1992-09-15 | 1997-01-28 | メレル ダウ ファーマスーティカルズ インコーポレイテッド | タモキシフェン抵抗性腫瘍の処置用の非代謝性クロミフェン類似体類 |
| US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| US5604248A (en) * | 1994-05-05 | 1997-02-18 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| US5470883A (en) * | 1994-05-23 | 1995-11-28 | Stromberg; Brent V. | Method of treating peripheral vasoconstriction with tamoxifen citrate |
| ATE377418T1 (de) * | 1995-06-07 | 2007-11-15 | Poniard Pharmaceuticals Inc | Vorbeugung und behandlung von kardiovaskulären beschwerden mit tamoxifen-analogen |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
| US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
-
1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/es unknown
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/xx unknown
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Ceased
- 1997-09-03 PL PL97332278A patent/PL332278A1/xx unknown
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Ceased
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/ko not_active Withdrawn
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 PL PL97332038A patent/PL332038A1/xx unknown
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/xx unknown
- 1997-09-03 EP EP97942388A patent/EP0927029A4/en not_active Withdrawn
- 1997-09-03 JP JP51283798A patent/JP2002515046A/ja active Pending
- 1997-09-03 BR BR9711681A patent/BR9711681A/pt not_active Application Discontinuation
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 JP JP51283898A patent/JP2002515047A/ja active Pending
- 1997-09-03 CN CN97199493A patent/CN1236313A/zh active Pending
- 1997-09-03 EP EP97940773A patent/EP0929216A4/en not_active Withdrawn
- 1997-09-03 BR BR9711676A patent/BR9711676A/pt not_active Application Discontinuation
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/cs unknown
- 1997-09-03 IL IL12864597A patent/IL128645A0/xx unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/ko not_active Withdrawn
- 1997-09-03 CN CN97199492A patent/CN1236299A/zh active Pending
- 1997-09-04 CO CO97051289A patent/CO5070658A1/es unknown
- 1997-09-04 CO CO97051287A patent/CO4920218A1/es unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/zh active
-
1999
- 1999-03-05 NO NO991096A patent/NO991096L/no not_active Application Discontinuation
- 1999-03-05 NO NO991097A patent/NO991097D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002515047A (ja) | 2002-05-21 |
| CO4920218A1 (es) | 2000-05-29 |
| CN1236299A (zh) | 1999-11-24 |
| NO991096D0 (no) | 1999-03-05 |
| PL332278A1 (en) | 1999-08-30 |
| CZ76699A3 (cs) | 1999-08-11 |
| WO1998009619A1 (en) | 1998-03-12 |
| IL128645A0 (en) | 2000-01-31 |
| EP0929216A4 (en) | 2001-04-04 |
| WO1998009519A1 (en) | 1998-03-12 |
| TR199900506T2 (xx) | 1999-07-21 |
| KR20000068472A (ko) | 2000-11-25 |
| EP0927029A1 (en) | 1999-07-07 |
| NO991097L (no) | 1999-03-05 |
| NO991097D0 (no) | 1999-03-05 |
| AU4247397A (en) | 1998-03-26 |
| EP0929216A1 (en) | 1999-07-21 |
| TR199900504T2 (xx) | 1999-06-21 |
| CA2264943A1 (en) | 1998-03-12 |
| EP0927029A4 (en) | 2001-06-13 |
| JP2002515046A (ja) | 2002-05-21 |
| TW411273B (en) | 2000-11-11 |
| NO991096L (no) | 1999-03-05 |
| CO5070658A1 (es) | 2001-08-28 |
| CN1236313A (zh) | 1999-11-24 |
| AU4409797A (en) | 1998-03-26 |
| BR9711681A (pt) | 1999-08-24 |
| PL332038A1 (en) | 1999-08-16 |
| BR9711676A (pt) | 1999-08-24 |
| CA2264775A1 (en) | 1998-03-12 |
| KR20000068473A (ko) | 2000-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2190472T3 (es) | Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno. | |
| ATE107858T1 (de) | Pharmazeutische zusammensetzung zum abnehmen. | |
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| MX9703694A (es) | Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel. | |
| NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
| ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
| DE69738615D1 (de) | Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt | |
| BR0108977A (pt) | Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina | |
| MY132705A (en) | Novel compounds with analgesic effect | |
| YU49026B (sh) | UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE | |
| PT777482E (pt) | Composicao de combinacao para utilizacao em doencas imunologicas | |
| ATE100320T1 (de) | Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten. | |
| PT1173201E (pt) | Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina | |
| DE68912195D1 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| AR008155A1 (es) | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| EE9800315A (et) | Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil | |
| KR910009267A (ko) | 우울증의 치료방법 | |
| AR003979A1 (es) | Administracion transdermica de vorozol. | |
| AR004330A1 (es) | Uso de inhibidores de colinesterasa en el tratamiento de xerostomia | |
| DE69729201T2 (de) | Sulfonfluoride zur behandlung von der alzheimerischen krankheit | |
| AR012638A1 (es) | Uso de pregnan-3-ol-20-onas para la manufactura de un medicamento util para proveer una terapia progestacional | |
| MX9301879A (es) | Medicamento para el tratamiento de la inflamacion de las vias respiratorias | |
| DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. |